載入...
Feasibility of reduced-dose posttransplant cyclophosphamide and cotransplantation of peripheral blood stem cells and umbilical cord-derived mesenchymal stem cells for SAA
Posttransplant cyclophosphamide (PTCy) as graft-versus-host disease (GVHD) prophylaxis is an effective strategie for patients receiving matched sibling donor hematopoietic stem cell transplantation (MSD-HSCT) and haploidentical HSCT (haplo-HSCT). We evaluated the effectiveness and safety of reduced-...
Na minha lista:
發表在: | Sci Rep |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
Nature Publishing Group UK
2021
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7794355/ https://ncbi.nlm.nih.gov/pubmed/33420287 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-80531-7 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|